Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

Affiliations

¹ International Agency for Research on Cancer, Lyon, France. robbinsh@iarc.fr.
² International Agency for Research on Cancer, Lyon, France.
³ The Institute of Cancer Research, London, UK.
⁴ University of Cambridge, Cambridge, UK.
⁵ Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁶ University of Manchester, Manchester, UK.
⁷ Leeds Teaching Hospitals, Leeds, UK.
⁸ Nottingham University Hospitals and University of Nottingham, Nottingham, UK.
⁹ Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Published Erratum

Hilary A Robbins et al. Br J Cancer. 2021 Jul.

. 2021 Jul;125(2):305.

doi: 10.1038/s41416-021-01436-4.

¹ International Agency for Research on Cancer, Lyon, France. robbinsh@iarc.fr.
² International Agency for Research on Cancer, Lyon, France.
³ The Institute of Cancer Research, London, UK.
⁴ University of Cambridge, Cambridge, UK.
⁵ Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁶ University of Manchester, Manchester, UK.
⁷ Leeds Teaching Hospitals, Leeds, UK.
⁸ Nottingham University Hospitals and University of Nottingham, Nottingham, UK.
⁹ Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Erratum for

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA, Alcala K, Swerdlow AJ, Schoemaker MJ, Wareham N, Travis RC, Crosbie PAJ, Callister M, Baldwin DR, Landy R, Johansson M. Robbins HA, et al. Br J Cancer. 2021 Jun;124(12):2026-2034. doi: 10.1038/s41416-021-01278-0. Epub 2021 Apr 12. Br J Cancer. 2021. PMID: 33846525 Free PMC article.